Skip to main content

Table 4 Estimates of prevalence of hypertension and pre-hypertension among iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

 

Pre-hypertensiona

Hypertension

 

National

estimateb

Prevalence

(95% CI)

National

estimateb

Prevalence

(95% CI)

Age

    

   25–34 (n = 1081)

5.0

39.0 (35.3–42.8)

1.8

14.0 (11.5–17.0)

   35–44 (n = 1113)

3.6

39.8 (36.1–43.7)

2.3

25.2 (22.6–28.1)

   45–54 (n = 1069)

2.5

39.1 (35.9–42.4)

2.4

38.4 (35.0–41.9)

   55–64 (n = 970)

1.0

28.7 (25.5–32.0)

1.9

56.4 (52.4–60.3)

Sex

    

   Males (n = 2121)

7.1

44.3 (41.3–47.3)

3.9

24.7 (22.1–27.4)

   Females (n = 2112)

4.9

31.9 (29.4–34.4)

4.4

28.6 (25.1–32.3)

Residential area

    

   Urban (n = 2853)

8.6

38.0 (35.7–40.4)

6.3

28.2 (25.7–30.9)

   Rural (n = 1380)

3.4

38.4 (34.4–42.6)

2.0

22.6 (18.6–27.1)

Total national estimate

(n = 4233)

12.0

38.2 (36.1–40.2)

8.4

26.6 (24.4–28.9)

  1. CI: confidence interval
  2. a In non-hypertension subjects
  3. b Rounded to the nearest million
  4. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006